By 
Scientists in the U.S. are ramping up a national effort to evaluate COVID-19 vaccine candidates at clinical trial sites across the country, including locally at Saint Louis University Center for Vaccine Development and Washington University School of Medicine.
Both universities have been tapped to join the historic effort to find a COVID-19 vaccine that can prevent the illness, and expect to enroll about 3,000 participants in several COVID-19 vaccine trials, with each school participating in different trials.
Researchers say it will be critically important to enroll participants who are likely to be exposed to COVID-19 or those at risk for severe disease from COVID-19, including participants over age 65.
Comments